These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24892463)

  • 1. Diabetes guidelines may delay timely adjustments during treatment and might contribute to clinical inertia.
    Pimazoni-Netto A; Zanella MT
    Diabetes Technol Ther; 2014 Nov; 16(11):768-70. PubMed ID: 24892463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical inertia to insulin initiation and intensification in the UK: A focused literature review.
    Khunti K; Millar-Jones D
    Prim Care Diabetes; 2017 Feb; 11(1):3-12. PubMed ID: 27727005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving glycemic control in medical inpatients: a pilot study.
    Trujillo JM; Barsky EE; Greenwood BC; Wahlstrom SA; Shaykevich S; Pendergrass ML; Schnipper JL
    J Hosp Med; 2008 Jan; 3(1):55-63. PubMed ID: 18257047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with poor glycemic control among patients with type 2 diabetes.
    Khattab M; Khader YS; Al-Khawaldeh A; Ajlouni K
    J Diabetes Complications; 2010; 24(2):84-9. PubMed ID: 19282203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive insulin protocol implementation and outcomes in the medical and surgical wards at a Veterans Affairs Medical Center.
    Chen HJ; Steinke DT; Karounos DG; Lane MT; Matson AW
    Ann Pharmacother; 2010 Feb; 44(2):249-56. PubMed ID: 20103610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interprofessional qualitative study of barriers and potential solutions for the safe use of insulin in the hospital setting.
    Rousseau MP; Beauchesne MF; Naud AS; Leblond J; Cossette B; Lanthier L; Grondin F; Bernier F
    Can J Diabetes; 2014 Apr; 38(2):85-9. PubMed ID: 24690502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-monitoring of blood glucose is associated with problem-solving skills in hyperglycemia and hypoglycemia.
    Wang J; Zgibor J; Matthews JT; Charron-Prochownik D; Sereika SM; Siminerio L
    Diabetes Educ; 2012; 38(2):207-18. PubMed ID: 22454405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Guidelines for Inpatient Pharmacologic Management of Type 2 Diabetes in Adults and Glycemic Outcomes.
    Alkhiari R; Alzayer H; Aljazeeri J; Vanniyasingam T; Punthakee Z
    Can J Diabetes; 2018 Apr; 42(2):158-162. PubMed ID: 28662968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study].
    Spirk D; Lareida J; Scheidegger K; Diem P
    Praxis (Bern 1994); 2009 Mar; 98(6):315-20. PubMed ID: 19291638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical inertia in management of T2DM.
    Zafar A; Davies M; Azhar A; Khunti K
    Prim Care Diabetes; 2010 Dec; 4(4):203-7. PubMed ID: 20719586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after discharge.
    Bode B; Amin A
    Hosp Pract (1995); 2009 Dec; 37(1):7-21. PubMed ID: 20720383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy to reduce emergency department visits for uncontrolled hyperglycemia.
    Magee MF; Nassar CM; Copeland J; Fokar A; Sharretts JM; Dubin JS; Smith MS
    Diabetes Educ; 2013; 39(3):354-64. PubMed ID: 23610182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM.
    Kesavadev J; Sadikot S; Wangnoo S; Kannampilly J; Saboo B; Aravind SR; Kalra S; Makkar BM; Maji D; Saikia M; Anjana RM; Rajput R; Singh SK; Shah S; Dhruv U; Vishwanathan V
    Diabetes Metab Syndr; 2014; 8(3):187-95. PubMed ID: 25200925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.
    Shogbon AO; Levy SB
    Am J Health Syst Pharm; 2010 May; 67(10):798-805. PubMed ID: 20479101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic inertia amongst general practitioners with interest in diabetes.
    Seidu S; Than T; Kar D; Lamba A; Brown P; Zafar A; Hussain R; Amjad A; Capehorn M; Martin E; Fernando K; McMoran J; Millar-Jones D; Kahn S; Campbell N; Brice R; Mohan R; Mistry M; Kanumilli N; St John J; Quigley R; Kenny C; Khunti K
    Prim Care Diabetes; 2018 Feb; 12(1):87-91. PubMed ID: 28993141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes.
    Cahn A; Cefalu WT
    Diabetes Care; 2016 Aug; 39 Suppl 2(Suppl 2):S137-45. PubMed ID: 27440826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical implications of the revised guidelines for inpatient glycemic control.
    Reider J; Donihi A; Korytkowski MT
    Pol Arch Med Wewn; 2009 Dec; 119(12):801-9. PubMed ID: 20010466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.